Search database
Filter
28
Text search: Covaxin
Featured
Language
Document type
Guidelines
10
Fact sheets
7
Studies & Reports
4
Online Courses
3
Situation Updates
2
Resource Platforms
2
Countries / Regions
India
4
Ukraine
4
China
3
Middle East and North Africa
3
Russia
3
Paraguay
2
Germany
1
Brazil
1
Latin America and the Carribbean
1
Africa
1
Authors & Publishers
World Health Organization WHO
13
Africa CDC Centres for Disease Control and Prevention
3
African Union
3
Open WHO
3
Bharat Biotech
1
Ministerio de Salud Pública, Paraguay
1
Ministério da Saúde, Brasil
1
Ministry of Health& Family Welfare, Goverment of India
1
OCHA Services reliefweb
1
Organisation Mondiale de la Santé OMS
1
Organización Mundial de la Salud OMS
1
Organización Panamericana de la Salud
1
PAHO
1
Pan American Health Organisation PAHO
1
Pan American Health Organisation PAHO, et al.
1
UK Health Security Agency
1
Vygen-Bonnet S, Koch J, Bogdan C, et al.
1
WHO
1
World Health Organization WHO, Regional Office of Europe
1
Publication Years
Category
Countries
14
Clinical Guidelines
2
Toolboxes
COVID-19
24
Conflict
1
Refugee
1
Global Health Education
1
11 august 2022, updated version
24 September 2021. The vaccine has been authorized by the Chinese National Regulatory Authority (NRA) – the National Medicinal Product Administration (NMPA) – as well as other regulatory authorities. Because WHO has granted Emergency Use Listing (EUL) for the COVID-19 Vaccine BIBP/ Sinopharm, th ... more
24 September 2021. The vaccine has been authorized by the Chinese National Regulatory Authority (NRA) – the National Medicinal Product Administration (NMPA) – as well as other regulatory authorities. Because WHO has granted Emergency Use Listing (EUL) for the Sinovac COVID-19 vaccine (Vero Cell ... more
interim guidance, 19 July 2021 (arabic version)
A rapid evidence briefing. Vaccinated people are less likely to develop long COVID, even if they get infected, a rapid review of 15 studies by the UK Health Security Agency shows.
O Informe Semanal de Evidências sobre Variantes de Atenção do SARS-CoV-2 é uma produção organizada pelo Departamento de Ciência e Tecnologia da Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde do Ministério da Saúde (DECIT/SCTIE/MS). O documento tem o objetiv ... more
The COVID-19 pandemic has raised profound ethical challenges on an unprecedented global scale. These challenges include how to allocate scarce resources (especially vaccines and therapeutics), both within and between countries, whether and when to mandate vaccines and/or masks, whether and how to co ... more